CURRICULUM VITAE

CONTACT INFORMATION

Business Address: University of Maryland Medical Center

E-mail: nhanna@som.umaryland.edu

EDUCATION

1989-1993 Resident in Surgery, PGY I - IV, Department of Surgery, St. Elisabeth’s Medical Center, Tufts University School of Medicine, Boston, MA

1993-1994 Chief Surgical Resident, Department of Surgery, St. Elizabeth’s Medical Center, Tufts University School of Medicine, Boston, MA

POST GRADUATE COURSES

1995 Cryotherapy for Hepatic Tumors, University of Chicago

2000 Young Surgical Investigators Conference, American College of Surgeons

2000 Course in Clinical Trial Methods, American College of Surgeons

2017 Train-the-Trainer Program: Relationship-Centered Communication Skills

CERTIFICATIONS

MEDICAL LICENSURES

Egypt Medical License (Inactive)

State of Massachusetts (Inactive)

Academic Appointments

1998-2004 Assistant Professor of Surgery, Department of Surgery, University of Kentucky School of Medicine, Lexington, KY

1994-1998 Trauma Surgeon, Lutheran General Hospital, Park Ridge, IL

1998-2004 Staff Surgeon, Veterans Administration Medical Center, Cooper Drive Division, Lexington, KY

2006-2015 Medical Director of the Surgical IMC unit, University of Maryland Medical center, Baltimore, MD

2009- 2012 Head, Division of Surgical Oncology, Department of Surgery, University of Maryland Medical center, Baltimore, MD

1997-present American College of Surgeons

2000-present American Society of Clinical Oncology

2017-present American Academy on Communications in Healthcare

HONORS AND AWARDS

2001, 2002 Abraham Flexner Master Educator Award for Outstanding

Teaching Contribution/Mentorship. A peer reviewed award recognizing outstanding faculty who had made significant contributions in the education program in the College of Medicine at the University of Kentucky.

2009-2020 America’s Top Doctors for Cancer, Castle Connolly Medical

2010-2020 America’s Top Doctors, Castle Connolly Medical

1. Weill Cornell Medical College, New York. 10/28/2012.

2. NCI, Cairo, Egypt. 5/13/2014.

7. Assiut University School of Medicine, Egypt. 11/11-11/14/2018.

8. University of Aswan School of Medicine, Egypt. 8/26/19-8/29/2019.

- Retroperitoneal and extremity soft tissue sarcoma.

- Minimally invasive surgery for cancer including laparoscopic and robotic surgery for colorectal, gastric, distal pancreatic, liver and adrenal tumors.

The focus of my clinical research includes population studies of treatment outcomes in GI malignancies, development of a post-operative clinical care pathway following major gastrointestinal cancer surgery; identifying predictors of recurrence and survival in patients undergoing CRS and HIPEC, identification of factors that correlate with post-operative outcome and complications following CRS and HIPEC.

Laboratory Research:

2. Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal surface malignancies (PI)

3. Sarcoma treatment outcomes. (PI)

8. Screening Protocol for Eligibility Determination for Clinical Trials Evaluating Safety and Efficacy of Autologous T Cells Expressing Enhanced TCRs in Subjects with Solid or Hematological Malignancies. (Co-PI)

9. An Umbrella Protocol for the Collection of Blood and Biological Samples from Patients with Established or Suspected Gastrointestinal or Abdominal Malignancies or Melanoma to Be Used in Laboratory Research. (Co-PI)

14. International Survey METSURVEY. (Co-PI)

Research Collaboration

2001-2004 Anatomic Pathology Tissue Committee, University of Kentucky

2001-2004 Surgery Research Committee, University of Kentucky

2003-2004 Graduate Medical Education Internal Residency Reviewer for Surgery, University of Kentucky College of Medicine

Institutional Service (University of Maryland)

2004-2015, 17-19 Chair, Cancer Committee, University of Maryland Greenebaum Cancer Center, UMSOM

2004- 2009 Cancer Liaison Physician, University of Maryland Greenebaum Cancer Center, UMSOM

2005-Present Tenure and Promotion Committee, Department of Surgery, UMSOM

2006-2015 Medical Director of the Surgical IMC unit, University of Maryland Medical center, Baltimore, MD

2009-2012 Leader of the “Fairway to Life Breast Care Center” at UMGCC, accredited by the National Accreditation Program for Breast Care Center (NAPBC)

2009-2012 Head, Division of Surgical Oncology, Department of Surgery, UMSOM

2012-2013 School of Medicine Council Alternate Representatives for the Department of Surgery

2012-Present VTE task force core measure committee member

2016- Present UMMS Cancer Network Quality Physician Champion

2018- Present University of Maryland School of Medicine Council

Associate Society of the American College of Surgeons

2001-2002 Society of Surgical Oncology Fellowship-Research Grant Committee

2012 American College of Surgeons’ representative in the selection of the ACS/SSAT Health Policy Scholar

2012 The Jahnigen Career Development Awards (JCDA)/Grants for Early Medical/Surgical Subspecialists' Transition to Aging Research (GEMSSTAR) Selection Committee, American College of Surgeons (ACS)

2017-2019 Chair, International Fellowship Subcommittee, American College of Surgeons

2017- Present The Alliance/ACS CRP Cancer Care Standards Development Committee, American College of Surgeons

2020 Expert panel member, SSO Virtual Tumor Board: Colorectal disease and COVID-19

2019-2021 Vice Chair, International Relationship Committee, ACS

2021-2026 Consultant for the Complex General Surgical Oncology Continuous Certification Assessment, American Board of Surgery.

International Service

Carolina, Puerto Rico. 2/2010

2011 Chair, Esophageal & Gastrointestinal Session, 4th World Cancer Congress, Dalian, China. 6/2011

2013- Present Advisory Board, Ain Shams Medical Students Research Association (AMSRA)

2014 Panelist & invited speaker at 3^rd International Gastrointestinal and Liver Oncology Conference for “Tailoring Guidelines in multidisciplinary management of metastatic colorectal cancer aiming at regional recommendation” session. Cairo, Egypt.

2016 Meet the Professor Session: Pseudomyxoma Peritonei: Follow-up and Management of Recurrent disease. 10^th International Congress on Peritoneal Surface Malignancies. Washington, DC. 11-19-2016

2018 Scientific Committee, 18^th Annual Conference of Egyptian Society of Surgical Oncology, Egyptian Cancer Society, Society of Surgical Oncology (USA). Cairo, Egypt 4/11-4/13/2018.

2019 Video Session: Left upper abdominal quadrantectomy. Surgi-Alex 2019, University of Alexandria, Alexandria, Egypt 4/7/19-4/12/19.

EDITORIAL BOARD

Annals of Surgical Oncology

Journal of Clinical Oncology

Surgical Innovation

International journal Of Hyperthermia

NIH GRANT REVIEWERS

Meeting Title: Subcommittee J - Career Development

Medical Students

2004-Present Attending Physician, in-patient surgical service

6 contact hours/clinic day, 9 months/year

2004-Present Weekly inpatient surgical oncology team teaching rounds (1day/week)

2005-2009 Mentor and course director for sub-I students rotating through Surgical Oncology (GSUR 549). 1 student/3 weeks through weeks 1-44

2004-2015 Initiated and in charge of weekly didactic surgical oncology teaching conference, during which each student is required to give a power point presentation on a cancer-related topic

2016 Medical student research day Judge

2020 Medical student research day Judge

• Gastric Cancer

• Hepatobiliary-pancreatic malignancies

2006-Present Radiation oncology residents/fellows lecture series

2006-Present Medical Oncology fellows lecture series

2008-2010 Cancer Biology Course-GPILS 665 (6 contact hours, 6-8 graduate students/year):

• Clinical Aspects of Breast Cancer

2005-Present Course director, weekly multidisciplinary gastro-intestinal tumor conference, University of Maryland Greenebaum Cancer Center, UMSOM

2009-2011 1st, 2nd, and 3rd Annual Multidisciplinary Gastro-Intestinal Cancer Symposium, UMSOM

2017 The 11^th Annual Cancer Symposium “Integrative Cancer Care and Symptom Management”, UM-SJMC Cancer institute, 11/2017

2018 The 12^th Annual Cancer Symposium “Management of Patients During Active Cancer Treatment”, UM-SJMC Cancer institute, 11/2018

PRECEPTOR/MENTORSHIP ACTIVITIES

2000-2004 Mentor for Summer Research Fellowship Program (8 weeks) for medical students, University of Kentucky.

2005-2009 Mentor and course director for sub-I students rotating through Surgical Oncology (GSUR 549), UMSOM.1 student/3 weeks through weeks 1-44.

2010-2011 Faculty advisor for PhD candidate; Masayo Sato, BSPharm, MS, Department of Pharmaceutical Health Services Research, University of Maryland

2012 Dissertation Faculty for graduate student Masayo Sato’s PhD thesis; “Impact of Erythropoiesis Stimulating Agents on Survival and Risk of Venous Thromboembolism Among Patients with Colorectal Cancer Receiving Chemotherapy”

GRANT SUPPORT

Active Grants

1999 N. Hanna (PI)

“Exploitation of Tumor Hypoxia for Pancreatic Cancer Radiosensitization”

“An Open-Label, Phase I, Dose-Escalation Study of Tumor Necrosis actor alpha (TNFerade Biologic) Gene Therapy with

Radiation for Locally Advanced, Recurrent or Metastatic Solid

“Exploitation of Tumor Hypoxia for Pancreatic Cancer Radiosensitization”

Society of Surgical Oncology Fellowship award for Basic Research

6,300.00 (Direct costs: $5,000.00)

2001 – 2004 N. Hanna (PI)

$29,321.00 (Direct cost: $ 23,271.00)

2002 N. Hanna (PI)

“A Randomized Phase II Study of TNFerade Biologic with 5-FU and

Radiation Therapy for First-Line Treatment of Unresectable Locally

Salary support for clinical research nurse coordinator

GenVec, Inc

advanced resectable esophageal cancer”

Gen Vec, Inc

based community and cancer center program, with focus on early

detection, molecular epidemiology and state-of-the art treatment for lung,

“Use and Outcomes of Novel Chemotherapeutic Agents in Colorectal

Cancer”

Schering –Plough

$5000.00

3/01/2009-3/01/2010 N. Hanna (Co. Inv. 5%; PI-Daniel Mullins)

“Treatment Patterns, Outcomes and Costs related to Colon Cancer”

Sanofi-Aventis

$155,115.00

BioCancell

11/1/10-6/30/12 N. Hanna (Co. Inv. 7.5%; PI-Fadia Shaya)

“A Phase III Study of Chemotherapy and Chemoradiotherapy with or without Hyper-Acute-Pancreas (algenpantucel-L) in Subjects with Surgically Resected Pancreatic Cancer”

Novartis

Complete List of Published Work in My Bibliography:

https://www.ncbi.nlm.nih.gov/myncbi/nader.hanna.1/bibliography/public/

2. Hanna NN, O'Donnell K, Wolfe GR. Alveolar soft part sarcoma metastatic to the breast. J Surg Oncol. 1996 Feb;61(2):159-62. PubMed PMID: 8606550.

3. Hanna NN, Hallahan DE, Wayne JD, Weischselbaum RR. Modification of the Radiation Response by the Administration of Exogenous Genes. Semin Radiat Oncol. 1996 Oct;6(4):321-328. PubMed PMID: 10717189.

8. Mauceri HJ, Hanna NN, Staba MJ, Beckett MA, Kufe DW, Weichselbaum RR. Radiation-inducible gene therapy. C R Acad Sci III. 1999 Feb-Mar;322(2-3):225-8. Review. PubMed PMID: 10196676.

9. Hanna NN, Kenady DE. Hypertension in patients with pheochromocytoma. Curr Hypertens Rep. 1999 Dec;1(6):540-5. PubMed PMID: 10981118.

14. Mohiuddin M, Kudrimoti M, Regine WF, McGrath PC, Hanna N, John W. Concurrent infusional gemcitabine and radiation in the treatment of advanced unresectable GI malignancy: a phase I study. Cancer J. 2002 May-Jun;8(3):255-62. PubMed PMID: 12074325.

15. Hanna NN, Guillem J, Dosoretz A, Steckelman E, Minsky BD, Cohen AM. Intraoperative parasympathetic nerve stimulation with tumescence monitoring during total mesorectal excision for rectal cancer. J Am Coll Surg. 2002 Oct;195(4):506-12. PubMed PMID: 12375756.

20. Hanna NN. Radiofrequency ablation of primary and metastatic hepatic malignancies. Clin Colorectal Cancer. 2004 Jul;4(2):92-100. Review. PubMed PMID: 15285816.

21. Mundt AJ, Vijayakumar S, Nemunaitis J, Sandler A, Schwartz H, Hanna N, Peabody T, Senzer N, Chu K, Rasmussen CS, Kessler PD, Rasmussen HS, Warso M, Kufe DW, Gupta TD, Weichselbaum RR. A Phase I trial of TNFerade biologic in patients with soft tissue sarcoma in the extremities. Clin Cancer Res. 2004 Sep 1;10(17):5747-53. PubMed PMID: 15355902.

26. Alexander HR, Hanna N, Pingpank JF. Clinical results of cytoreduction and HIPEC for malignant peritoneal mesothelioma. Cancer Treat Res. 2007;134:343-55. Review. PubMed PMID: 17633065.

27. Regine WF, Hanna N, Garofalo MC, Doyle A, Arnold S, Kataria R, Sims J, Tan M, Mohiuddin M. Low-dose radiotherapy as a chemopotentiator of gemcitabine in tumors of the pancreas or small bowel: a phase I study exploring a new treatment paradigm. Int J Radiat Oncol Biol Phys. 2007 May 1;68(1):172-7. Epub 2007 Feb 2. PubMed PMID: 17276612.

32. Turner PL, Ilano AG, Zhu Y, Johnson SB, Hanna N. ACS-NSQIP criteria are associated with APACHE severity and outcomes in critically ill surgical patients. J Am Coll Surg. 2011 Mar;212(3):287-94. doi: 10.1016/j.jamcollsurg.2010.12.011. PubMed PMID: 21356486.

33. Hanna NN, Bellavance E, Keay T. Palliative surgical oncology. Surg Clin North Am. 2011 Apr;91(2):343-53, viii. doi: 10.1016/j.suc.2010.12.004. PubMed PMID: 21419257.

38. Janne d'Othée B, Sofocleous CT, Hanna N, Lewandowski RJ, Soulen MC, Vauthey JN, Cohen SJ, Venook AP, Johnson MS, Kennedy AS, Murthy R, Geschwind JF, Kee ST. Development of a research agenda for the management of metastatic colorectal cancer: proceedings from a multidisciplinary research consensus panel. J Vasc Interv Radiol. 2012 Feb;23(2):153-63. doi: 10.1016/j.jvir.2011.12.003. PubMed PMID: 22264550; PubMed Central PMCID: PMC4352314.

39. Zhang G, Schetter A, He P, Funamizu N, Gaedcke J, Ghadimi BM, Ried T, Hassan R, Yfantis HG, Lee DH, Lacy C, Maitra A, Hanna N, Alexander HR, Hussain SP. DPEP1 inhibits tumor cell invasiveness, enhances chemosensitivity and predicts clinical outcome in pancreatic ductal adenocarcinoma. PLoS One. 2012;7(2):e31507. doi: 10.1371/journal.pone.0031507. Epub 2012 Feb 20. PubMed PMID: 22363658; PubMed Central PMCID: PMC3282755.

44. Yovino S, Maidment BW 3rd, Herman JM, Pandya N, Goloubeva O, Wolfgang C, Schulick R, Laheru D, Hanna N, Alexander R, Regine WF. Analysis of local control in patients receiving IMRT for resected pancreatic cancers. Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):916-20. doi: 10.1016/j.ijrobp.2011.08.026. Epub 2012 Jan 25. PubMed PMID: 22284684; PubMed Central PMCID: PMC3556989.

45. Hanna N, Bikov KA, McNally D, Onwudiwe NC, Dalal M, Mullins CD. Impact of venous thromboembolism on mortality of elderly Medicare patients with stage III colon cancer. Oncologist. 2012;17(9):1191-7. Epub 2012 Jul 5. PubMed PMID: 22767876; PubMed Central PMCID: PMC3448412.

50. Lissauer ME, Diaz JJ, Narayan M, Shah PK, Hanna NN. Surgical intensive care unit admission variables predict subsequent readmission. Am Surg. 2013 Jun;79(6):583-8. PubMed PMID: 23711267.

51. Alexander HR Jr, Bartlett DL, Pingpank JF, Libutti SK, Royal R, Hughes MS, Holtzman M, Hanna N, Turner K, Beresneva T, Zhu Y. Treatment factors associated with long-term survival after cytoreductive surgery and regional chemotherapy for patients with malignant peritoneal mesothelioma. Surgery. 2013 Jun;153(6):779-86. doi: 10.1016/j.surg.2013.01.001. Epub 2013 Mar 13. PubMed PMID: 23489943; PubMed Central PMCID: PMC3734959.

56. Jain A, Poonia B, So EC, Vyzasatya R, Burch EE, Olsen HS, Mérigeon EY, Block DS, Zhang X, Schulze DH, Hanna NN, Twadell WS, Yfantis HG, Chan SL, Cai L, Strome SE. Tumour antigen targeted monoclonal antibodies incorporating a novel multimerisation domain significantly enhance antibody dependent cellular cytotoxicity against colon cancer. Eur J Cancer. 2013 Oct;49(15):3344-52. doi: 10.1016/j.ejca.2013.06.009. Epub 2013 Jul 18. PubMed PMID: 23871153.

57. Reese ES, Onukwugha E, Hanna N, Seal BS, Mullins CD. Clinical and demographic characteristics associated with the receipt of chemotherapy treatment among 7951 elderly metastatic colon cancer patients. Cancer Med. 2013 Dec;2(6):907-15. doi: 10.1002/cam4.143. Epub 2013 Oct 10. PubMed PMID: 24403264; PubMed Central PMCID: PMC3892395.

62. Zheng Z, Onukwugha E, Hanna N, Bikov K, Seal B, Mullins CD. Cost-effectiveness of second-line chemotherapy/biologics among elderly metastatic colon cancer patients. Adv Ther. 2014 Jul;31(7):724-34. doi: 10.1007/s12325-014-0134-8. Epub 2014 Jul 15. PubMed PMID: 25022528; PubMed Central PMCID: PMC4115177.

63. Thom KA, Standiford HC, Johnson JK, Hanna N, Furuno JP. Effectiveness of an antimicrobial polymer to decrease contamination of environmental surfaces in the clinical setting. Infect Control Hosp Epidemiol. 2014 Aug;35(8):1060-2. doi: 10.1086/677159. Epub 2014 Jun 20. PubMed PMID: 25026625; PubMed Central PMCID: PMC4294176.

68. Katz SC, Point GR, Cunetta M, Thorn M, Guha P, Espat NJ, Boutros C, Hanna N, Junghans RP. Regional CAR-T cell infusions for peritoneal carcinomatosis are superior to systemic delivery. Cancer Gene Ther. 2016 May; 23(5):142-8. Epub 2016 Apr 15. PMID: 27080226

69. Woldemichael A, Onukwugha E, Seal B, Hanna N, Mullins CD. Sequential Therapies and the Cost-Effectiveness of Treating Metastatic Colon Cancer Patients. J Manag Care Spec Pharm. 2016 Jun; 22(6):628-39. doi: 10.18553/jmcp.2016.22.6.628. PMID: 27231791

74. Li YC, Khashab T, Terhune J, Eckert RL, Hanna N, Burke A, Richard Alexander H. Preoperative Thrombocytosis Predicts Shortened Survival in Patients with Malignant Peritoneal Mesothelioma Undergoing Operative Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy. Ann Surg Oncol. 2017 Aug;24(8):2259-2265. Epub 2017 Mar 21. PMID: 28324285

75. Nathenson MJ, Barysauskas CM, Nathenson RA, Regine WF, Hanna N, Sausville E. Surgical resection for recurrent retroperitoneal leiomyosarcoma and liposarcoma. World J Surg Oncol. 2018 Oct 11;16(1):203.

76. Max Seaton, Andrew Hanna, Cherif Boutros and Nader Hanna. Adjuvant therapy for pancreatic body or tail adenocarcinoma: a study of the National Cancer Database. Ther Adv Med Oncol. 2019 May 3;11:175

77. Brigit Baglien, Ledibabari M.Ngaage, CarlyRosen, Richelle Williams, Andrea C.Bafford, Erin M.Rada, Nader N. Hanna, Yvonne M.Rasko. Outcomes of complex abdominal wall reconstruction at the time of CRS and HIPEC. Surg Oncol. 2019 Sep;30:27-32.

78. The Chicago Consensus on Peritoneal Surface Malignancies: Management of Desmoplastic Small Round Cell Tumor, Breast, and Gastrointestinal Stromal Tumors. Ann Surg Oncol. 2020 Jun;27(6):1793-1797. doi: 10.1245/s10434-020-08319-7. Epub 2020 Apr 13. PubMed PMID: 32285268.

83. The Chicago Consensus on Peritoneal Surface Malignancies: Management of Ovarian Neoplasms. Ann Surg Oncol. 2020 Jun;27(6):1780-1787. doi: 10.1245/s10434-020-08322-y. Epub 2020 Apr 13. PubMed PMID: 32285271.

84. The Chicago Consensus on Peritoneal Surface Malignancies: Palliative Care Considerations. Ann Surg Oncol. 2020 Jun;27(6):1798-1804. doi: 10.1245/s10434-020-08323-x. Epub 2020 Apr 13. PubMed PMID: 32285272.

89. The Chicago Consensus Guidelines for peritoneal surface malignancies: Introduction. Cancer. 2020 Jun 1;126(11):2510-2512. doi: 10.1002/cncr.32827. Epub 2020 Apr 13. PubMed PMID: 32282062.

90. The Chicago Consensus on peritoneal surface malignancies: Standards. Cancer. 2020 Jun 1;126(11):2516-2524. doi: 10.1002/cncr.32825. Epub 2020 Apr 13. PubMed PMID: 32282066.

95. The Chicago Consensus on Peritoneal Surface Malignancies: Management of Appendiceal Neoplasms. Ann Surg Oncol. 2020 Jun;27(6):1753-1760. doi: 10.1245/s10434-020-08316-w. Epub 2020 Apr 13. PubMed PMID: 32285275.

96. The Chicago Consensus Guidelines for Peritoneal Surface Malignancies: Introduction. Ann Surg Oncol. 2020 Jun;27(6):1737-1740. doi: 10.1245/s10434-020-08318-8. Epub 2020 Apr 13. PubMed PMID: 32285277.

101. Global variation in postoperative mortality and complications after cancer surgery: a multicentre, prospective cohort study in 82 countries. GlobalSurg Collaborative and National Institute for Health Research Global Health Research Unit on Global Surgery. Lancet. 2021 Jan 30;397(10272):387-397.

None Peer-Reviewed Journal Articles

Joseph Scalea, Brnko Bojovic, Robin Legros, Julia Choi, Andrea Herbert, Nader Hanna. Angiosarcoma Following Radiation Therapy for Breast Cancer: Case Presentation and Clinical Management Considerations. Open Journal of Pathology 2013 October; 03(04):180-185

C.Boutros, N.Hanna. Totally Laparoscopic Cytoreductive surgery and Hyperthermic intraperitoneal chemotherapy for Mucinous Adneocarcinoma of the Appendix. Journal of Laparoendoscopic and Advanced Surgical Techniques. September 2014.

4. Hanna NN. Hereditary Diffuse Gastric Cancer Syndrome. In Encyclopedia of Diagnostic Genomic and Proteomics (Print and on line). Eds. Jurgen Fuches, Maurizio Podda. Publs. Marcel Dekker, Inc. 12/2004.

5. Pierece H, Hanna NN. Hereditary Breast and Ovarian Cancer Syndrome. In Encyclopedia of Diagnostic Genomic and Proteomics (Print and on line). Eds. Jurgen Fuches, Maurizio Podda. Publs. Marcel Dekker, Inc. 12/2004.

10. Alfred Cohen, Michael Garofalo, Philip De Simone, Nader Hanna NN, William Regine. “Rectal Cancer.” In Abeloff’s Clinical Oncology, 4^th Edition. Eds. Martin D. Abeloff, James O Armitage, John E. Niederhuber, Michael B. Kastan, W. Gillies McKenna. Publs. Churchill Livingston, May, 2008.

11. C.Boutros, H. Sobhi, N. Hanna. The evolution of abdominal wall reconstruction and the role of nanobiotecnology in the development of intelligent abdominal wall prostheses. In Nanobiomaterials for intelligent medical devices. Eds. Tiwari and Kobayashi. Publs. Wiley-Scrivener; February 1, 2012.

12. Colon & Rectum. AJCC Cancer Staging Manual / Edition 8. Eds. Stephen Edge, Frederick L. Greene, David R. Byrd, Robert K. Brookland, Mary Kay Washington. Publs. Springer; October 3, 2016.

13. Appendix. AJCC Cancer Staging Manual / Edition 8. Eds. Stephen Edge, Frederick L. Greene, David R. Byrd, Robert K. Brookland, Mary Kay Washington. Publs. Springer; October 3, 2016.

MAJOR INVITED SPEECHES

12. Advances in Surgical Management of Small Bowel Tumors. World Congress on Gastroenterology & Urology. 3/12/2012, Omaha, Nebraska, USA.

13. Surgical Management of Colorectal Metastasis. First conference of the Egyptian Chapter of American college of Surgeons. 9/7/12, Cairo, Egypt.

18. Comparative Effectiveness and Survival Benefit of Liver Directed Therapy, Systemic Chemotherapy and Radiation Therapy in Stage Four HCC: A SEER-Medicare Analysis. 75th Annual Surgical Update of the International College of Surgeons-US Section, June 6-8, 2013 in Jacksonville, Florida.

19. Cytoreductive Surgery & Hyperthermic Intraperitoneal Chemotherapy; Beyond Standard of Care Treatment. The Third International Gastrointestinal Cancer Conference. December13-15, 2013. Antalya, Turkey.

24. Is there a Role For Cytoreductive Surgery & Hyperthermic Intraperitoneal in Colorectal cancer? Annual Meeting of the Egyptian Society of Surgical oncology. February 13, 2015. Cairo, Egypt

25. Safety and Outcomes of CRS & HIPEC in the Elderly. Peritoneal Surface Malignancy Experts Meeting. Athens, Greece May 8, 9 2015.

30. Best Evidence-Based Practice for management of CRC. Aswan cancer Institute, Egypt. Visiting Professorship. 9/26/2016

31. Breast Cancer Awareness; Myth vs Reality. Aswan cancer Institute, Egypt. Visiting Professorship. 9/26/2016

36. Management of Hepatic Colorectal Metastasis. Helwan University, Egypt. Visiting Professorship 11/26-11/27/2017.

37. The AJCC Staging System: What is New for GIT/Liver Malignancies. Annual International Egyptian Oncology Summit, Luxor, Egypt 11/30-12/1/2017

42. Laparoscopic Liver Surgery. 7^th International Gastrointestinal, Liver, & Uro-oncology Conference, Cairo, Egypt 5/2018

43. Indications & Future Opportunities for CRS & HIPEC in CRC. 7^th International Gastrointestinal, Liver, & Uro-oncology Conference, Cairo, Egypt 5/2018

47. Sphincter Sparing Surgical Options in Cancer of the Rectum. New Trends in Minimally Invasive Surgery in the Treatment of GI Cancer Seminar, University of Kentucky, November12, 1999.

48. Anatomical and Pathological Considerations for Rectal Cancer Surgery. Department of Surgery Grand Rounds, University of Kentucky, April 8, 2000.

53. Surgical Evaluation and Management of Hepatobiliary Malignancies. The 34^th Annual Medicine Review Course, University of Kentucky. November 15, 2002.

54. Surgical Evaluation and Management of Hepatobiliary Malignancies. The 34^th Annual Medicine Review Course, University of Kentucky. February 21, 2003.

59. Challenges and evidenced-based surgery for pancreatic cancer. Department of Surgery Grand Rounds, University of Kentucky, May 5, 2004

60. Surgical Evaluation and Management of Early Breast Cancer. 2^nd Annual Breast Cancer Update. Baltimore, Maryland, November 19, 2004

65. Appropriate DVT Prophylaxis for at Risk Patients. Surgical Grand Rounds. St. Vincent Hospital. Green Bay, Wisconsin. March 28, 2007

66. GYN Grand Rounds: VTE Prophylaxis and Best Practice Measures in Patients Undergoing Abdominal Surgery. University of Tennessee, Knoxville, TN. 4/13/07

71. Optimal Management of Hepatic Colorectal Metastases. 1st Annual GI Cancer Symposium. April 2009

72. Cytoreductive Surgery and HIPEC: Post-operative Management. First workshop for Department of Defense Surgical Oncologist. Baltimore, MD June 1, 2009.

77. VTE Prophylaxis in Patients Undergoing Abdominal Surgery. Grand Rounds, Chester River Hospital, Chester Town, Maryland. 9/28/2011.

78. Surgery Update for hepatic CRC Metastasis. Society of Interventional Radiology Foundation’s Research Consensus Panel (RCP) on the Management of Metastatic Colorectal Cancer. Washington DC. 10/3/2011.

83. Gastric Cancer: Can HIPEC Improve Outcomes. Surgical Oncology at Mercy Conference “Peritoneal Dissemination of Cancer: Present Treatment, Guidelines and Controversies”, June 20-21, 2013. Baltimore, MD.

84. M & M in Gastric Cancer; Tough to Digest or Food for Thought. Visiting Professor Grand Round speaker. Weill Cornell Medical College. October 28, 2013, New York.

89. Colorectal Cancer Management: Evidence-Based Practice. Grand Rounds Presentation, St. Joseph Medical center, Baltimore, MD. 9/19/14

90. Quality Initiatives in the UM Cancer Network. 8^th Annual Cancer Symposium, University of Maryland St. Joseph Medical Center Cancer Institute. 11/4/2014

95. Neoadjuvant vs Adjuvant Therapy; A New Paradigm Shift in Management of PDAC. 4th NCI-Pancreatic cancer symposium. September 8, 9. 2016, NCI, Bethesda, MD.

96. Evidence-based Management of Gastric Cancer. Grand Rounds Presentation, Washington Hospital Center, Washington, D.C. 1/17/2017.

100. Genetics of Colorectal Cancer. Genetic Counseling graduate students, University of Maryland, March 2005.

101. Introduction to genetics of colorectal cancer. Clinical Cancer Genetics course for genetic counseling graduate students, University of Maryland, March 30, 2006

106. Surgical Management of Rectal Cancer. Medical Oncology Fellows Lecture Series 10/13/2006.

107. Pancreatic Cancer; Evidence-based Practice. Medical Oncology Fellows Lecture Series 10/27/2006.

112. Overview of colorectal cancer. Clinical Cancer Genetics course for genetic counseling undergraduate students, University of Maryland, March 29, 2008

113. Rectal Cancer: Surgical Prospective. Radiation Oncology lecture Series 12/3/08

118. Evidence-Based Surgery and Controversies in management of Gastric Cancer. Surgical Grand Round Speaker, Dept of Surgery, University of Maryland School of Medicine 4/29/10

119. Metastasectomies: Do They Really Work? Hematology Oncology. Grand Rounds Speaker, University of Maryland School of Medicine 5/3/10.

124. Cancer and Sexuality. Palliative care lecture series to surgical residents, University of Maryland 10/21/2010.

125. Colon and Rectal cancer. Third year student clerkship lecture series, University of Maryland 12/2/2010.

130. Rectal Tumors: How to Manage. Surgical Grand Rounds, University of Maryland, Baltimore, MD. 5/19/2011.

131. Gastric Cancer, Evidence-Based Practice. Surgery Resident Lecture series, University of Maryland, Baltimore, MD. 5/19/2011.

136. Biliary neoplasms. Surgery Resident Lecture series, University of Maryland, Baltimore, MD. 9/21/2017.

137. Malignant Small Bowel Tumors. Surgery Resident Lecture series, University of Maryland, Baltimore, MD. 12/20/2018.